» Articles » PMID: 28115940

Rare Occurrence of a Poorly Differentiated Neuroendocrine Tumor of the Bladder

Overview
Journal Case Rep Med
Publisher Wiley
Specialty General Medicine
Date 2017 Jan 25
PMID 28115940
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroendocrine tumors rarely occur in the urinary bladder. They can be carcinomatous, subdivided into small cell and large cell pathology. Small cell carcinoma of the bladder is a rarity that may present at an advanced pathologic stage. No treatment regimens have been standardized for local or metastatic disease. Review of the recent literature shows equivalent survival data for localized disease treated with chemoradiotherapy combined with either bladder sparing surgery or radical cystectomy. Patients with significant comorbidities are an additional challenge. We report a case of poorly differentiated neuroendocrine tumor of the bladder, which could not be classified as small or large cell carcinoma, complicated by significant comorbidities. After management with transurethral resection of the tumor, adjuvant chemotherapy, and radiation, the patient is alive and asymptomatic nearly 1 year after initial TURBT with no evidence of disease recurrence.

Citing Articles

Small cell neuroendocrine tumor of the urinary bladder: A case report.

Shetty D, Mashelkar A, Sharan A, S S Int J Surg Case Rep. 2025; 128:111045.

PMID: 39956028 PMC: 11872404. DOI: 10.1016/j.ijscr.2025.111045.


Large-cell neuroendocrine carcinoma of the bladder: A case report.

Zhou Y, Yang L World J Clin Oncol. 2024; 15(9):1239-1244.

PMID: 39351458 PMC: 11438854. DOI: 10.5306/wjco.v15.i9.1239.


Unusual Association of Large Cell Neuroendocrine Carcinoma of the Bladder and Prostatic Adenocarcinoma Within a 76-Year-Old Man.

Nassira K, Aberkane M, El Moudane A, Haloui A, Bennani A Cureus. 2024; 16(8):e67651.

PMID: 39314614 PMC: 11417971. DOI: 10.7759/cureus.67651.


Recurrent bladder urothelial carcinoma complicated with primary bladder large cell neuroendocrine carcinoma: a case report and literature review.

Cui J, Zhao Q, Yu C, Ma P, Li S Front Oncol. 2024; 14:1369649.

PMID: 39156709 PMC: 11327133. DOI: 10.3389/fonc.2024.1369649.


Primary Neuroendocrine Tumor of the Breast: Current Understanding and Future Perspectives.

Sun H, Dai S, Xu J, Liu L, Yu J, Sun T Front Oncol. 2022; 12:848485.

PMID: 35692784 PMC: 9174548. DOI: 10.3389/fonc.2022.848485.


References
1.
Thota S, Kistangari G, Daw H, Spiro T . A clinical review of small-cell carcinoma of the urinary bladder. Clin Genitourin Cancer. 2012; 11(2):73-7. DOI: 10.1016/j.clgc.2012.11.002. View

2.
Coelho H, Pereira B, Caetano P . Large cell neuroendocrine carcinoma of the urinary bladder: case report and review. Curr Urol. 2014; 7(3):155-9. PMC: 4024968. DOI: 10.1159/000356270. View

3.
Siefker-Radtke A, Kamat A, Grossman H, Williams D, Qiao W, Thall P . Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer. J Clin Oncol. 2009; 27(16):2592-7. PMC: 4879720. DOI: 10.1200/JCO.2008.19.0256. View

4.
Kouba E, Cheng L . Neuroendocrine Tumors of the Urinary Bladder According to the 2016 World Health Organization Classification: Molecular and Clinical Characteristics. Endocr Pathol. 2016; 27(3):188-99. DOI: 10.1007/s12022-016-9444-5. View

5.
Prelaj A, Rebuzzi S, Magliocca F, Speranza I, Corongiu E, Borgoni G . Neoadjuvant Chemotherapy in Neuroendocrine Bladder Cancer: A Case Report. Am J Case Rep. 2016; 17:248-53. PMC: 4831333. DOI: 10.12659/ajcr.896989. View